Cryoprobe transbronchial lung biopsy in patients after lung transplantation a pilot safety study

Research output: Contribution to journalArticle

Abstract

Background: Transbronchial biopsies using standard forceps (FTBBxs) are often limited by crush artifact and their small size. To date, there have been no studies aimed at assessing the safety and efficacy of cryoprobe biopsies (CPBxs) in the population of patients who have undergone lung transplants. We present the safety profile and biopsy results from the first 21 procedures in a pilot study comparing CPBx to FTBBx in patients after lung transplantation. Methods: Patients who had undergone lung transplant and who were scheduled for bronchoscopy were sequentially enrolled between November 2011 and September 2012. Inclusion criteria included age > 18 years and bilateral, orthotopic lung transplant. Exclusion criteria were coagulopathy, FEV1 <0.8 L, diffuse bullous disease, hemodynamic instability, and severe hypoxemia (PaO2 <55 mm Hg or SpO2 <92% on room air). Twenty-one procedures were performed, 10 using rigid bronchoscopy followed by 11 via flexible bronchoscopy. Patients were monitored for complications including pneumothorax, hemodynamic instability, and/or respiratory distress. Bleeding was categorized on an adapted grading system. Results: Twenty-one procedures in 17 patients (median age: 52 years; 12 male patients) were performed. Specimen area and percent open alveoli were significantly greater using CPBx compared with FTBBx (P <.05). No clinically significant procedural complications occurred and all patients were discharged the day of the procedure. Conclusions: The use of the cryoprobe is a safe, alternative technique to FTBBx during post-lung transplant bronchoscopy. Further studies are needed to determine if larger samples obtained with CPBx translate to an increased diagnostic yield.

Original languageEnglish (US)
Pages (from-to)621-626
Number of pages6
JournalChest
Volume143
Issue number3
DOIs
StatePublished - Mar 2013

Fingerprint

Lung Transplantation
Biopsy
Safety
Lung
Bronchoscopy
Transplants
Hemodynamics
Pneumothorax
Surgical Instruments
Artifacts
Air
Hemorrhage
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

@article{73dcd0c9519a46429c54838a6d3e7dd7,
title = "Cryoprobe transbronchial lung biopsy in patients after lung transplantation a pilot safety study",
abstract = "Background: Transbronchial biopsies using standard forceps (FTBBxs) are often limited by crush artifact and their small size. To date, there have been no studies aimed at assessing the safety and efficacy of cryoprobe biopsies (CPBxs) in the population of patients who have undergone lung transplants. We present the safety profile and biopsy results from the first 21 procedures in a pilot study comparing CPBx to FTBBx in patients after lung transplantation. Methods: Patients who had undergone lung transplant and who were scheduled for bronchoscopy were sequentially enrolled between November 2011 and September 2012. Inclusion criteria included age > 18 years and bilateral, orthotopic lung transplant. Exclusion criteria were coagulopathy, FEV1 <0.8 L, diffuse bullous disease, hemodynamic instability, and severe hypoxemia (PaO2 <55 mm Hg or SpO2 <92{\%} on room air). Twenty-one procedures were performed, 10 using rigid bronchoscopy followed by 11 via flexible bronchoscopy. Patients were monitored for complications including pneumothorax, hemodynamic instability, and/or respiratory distress. Bleeding was categorized on an adapted grading system. Results: Twenty-one procedures in 17 patients (median age: 52 years; 12 male patients) were performed. Specimen area and percent open alveoli were significantly greater using CPBx compared with FTBBx (P <.05). No clinically significant procedural complications occurred and all patients were discharged the day of the procedure. Conclusions: The use of the cryoprobe is a safe, alternative technique to FTBBx during post-lung transplant bronchoscopy. Further studies are needed to determine if larger samples obtained with CPBx translate to an increased diagnostic yield.",
author = "Lonny Yarmus and Jason Akulian and Christopher Gilbert and Illei, {Peter B} and Shah, {Pali Dedhiya} and Christian Merlo and Orens, {Jonathan B} and David Feller-Kopman",
year = "2013",
month = "3",
doi = "10.1378/chest.12-2290",
language = "English (US)",
volume = "143",
pages = "621--626",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3",

}

TY - JOUR

T1 - Cryoprobe transbronchial lung biopsy in patients after lung transplantation a pilot safety study

AU - Yarmus, Lonny

AU - Akulian, Jason

AU - Gilbert, Christopher

AU - Illei, Peter B

AU - Shah, Pali Dedhiya

AU - Merlo, Christian

AU - Orens, Jonathan B

AU - Feller-Kopman, David

PY - 2013/3

Y1 - 2013/3

N2 - Background: Transbronchial biopsies using standard forceps (FTBBxs) are often limited by crush artifact and their small size. To date, there have been no studies aimed at assessing the safety and efficacy of cryoprobe biopsies (CPBxs) in the population of patients who have undergone lung transplants. We present the safety profile and biopsy results from the first 21 procedures in a pilot study comparing CPBx to FTBBx in patients after lung transplantation. Methods: Patients who had undergone lung transplant and who were scheduled for bronchoscopy were sequentially enrolled between November 2011 and September 2012. Inclusion criteria included age > 18 years and bilateral, orthotopic lung transplant. Exclusion criteria were coagulopathy, FEV1 <0.8 L, diffuse bullous disease, hemodynamic instability, and severe hypoxemia (PaO2 <55 mm Hg or SpO2 <92% on room air). Twenty-one procedures were performed, 10 using rigid bronchoscopy followed by 11 via flexible bronchoscopy. Patients were monitored for complications including pneumothorax, hemodynamic instability, and/or respiratory distress. Bleeding was categorized on an adapted grading system. Results: Twenty-one procedures in 17 patients (median age: 52 years; 12 male patients) were performed. Specimen area and percent open alveoli were significantly greater using CPBx compared with FTBBx (P <.05). No clinically significant procedural complications occurred and all patients were discharged the day of the procedure. Conclusions: The use of the cryoprobe is a safe, alternative technique to FTBBx during post-lung transplant bronchoscopy. Further studies are needed to determine if larger samples obtained with CPBx translate to an increased diagnostic yield.

AB - Background: Transbronchial biopsies using standard forceps (FTBBxs) are often limited by crush artifact and their small size. To date, there have been no studies aimed at assessing the safety and efficacy of cryoprobe biopsies (CPBxs) in the population of patients who have undergone lung transplants. We present the safety profile and biopsy results from the first 21 procedures in a pilot study comparing CPBx to FTBBx in patients after lung transplantation. Methods: Patients who had undergone lung transplant and who were scheduled for bronchoscopy were sequentially enrolled between November 2011 and September 2012. Inclusion criteria included age > 18 years and bilateral, orthotopic lung transplant. Exclusion criteria were coagulopathy, FEV1 <0.8 L, diffuse bullous disease, hemodynamic instability, and severe hypoxemia (PaO2 <55 mm Hg or SpO2 <92% on room air). Twenty-one procedures were performed, 10 using rigid bronchoscopy followed by 11 via flexible bronchoscopy. Patients were monitored for complications including pneumothorax, hemodynamic instability, and/or respiratory distress. Bleeding was categorized on an adapted grading system. Results: Twenty-one procedures in 17 patients (median age: 52 years; 12 male patients) were performed. Specimen area and percent open alveoli were significantly greater using CPBx compared with FTBBx (P <.05). No clinically significant procedural complications occurred and all patients were discharged the day of the procedure. Conclusions: The use of the cryoprobe is a safe, alternative technique to FTBBx during post-lung transplant bronchoscopy. Further studies are needed to determine if larger samples obtained with CPBx translate to an increased diagnostic yield.

UR - http://www.scopus.com/inward/record.url?scp=84874960679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874960679&partnerID=8YFLogxK

U2 - 10.1378/chest.12-2290

DO - 10.1378/chest.12-2290

M3 - Article

VL - 143

SP - 621

EP - 626

JO - Chest

JF - Chest

SN - 0012-3692

IS - 3

ER -